| Patent application number | Description | Published |
|---|
| 20110228630 | Reduced Transit Static Mixer Configuration - Excessive residence time in the conduits located between the outlet of a static mixer and a reactor/separator reservoir can lead to undesired by-products, formation of solids, and conduit fouling. This disclosure relates to an improved configuration for a static mixer with reduced transitory time to help reduce the creation of undesired by-products and fouling during the process of mixing, and more particularly to a phosgene reactor comprising a short or very short conduit for reducing the transit time from the static mixer to a reactor/separator reservoir to one second or less. | 09-22-2011 |
| 20110230679 | Reactive Static Mixer - This disclosure relates to a static phosgene mixer, and more generally, to an apparatus for mixing of fluid components such as phosgene and amine during an highly reactive, chemical reaction that is vulnerable to the creation of undesired by-products, and equipment fouling. A guide element is disposed in the static mixer to divert the incoming flow of phosgene around the guide element and create an annular mixing passage in the static mixer. This allows for the use of an increased external radius of the effective phosgene flow while maintaining phosgene velocity by creating a blockage of the flow. The same flow, when transformed from a circular configuration to an annular configuration has an increased external radius, and a greater quantity of MDA jets can be placed along the increased radius, thus increasing the overall homogeneity of the mixture. Further, the cross-sectional area of the annular passage section of phosgene defined around the guide element controls the velocity of phosgene which facilitates the mixing of MDA injected through the jets into the phosgene. | 09-22-2011 |
| 20110242930 | REACTIVE STATIC MIXER - This disclosure relates to a static phosgene mixer, and more generally, to an apparatus for mixing of fluid components such as phosgene and amine during an highly reactive, chemical reaction that is vulnerable to the creation of undesired by-products, and equipment fouling. A guide element is disposed in the static mixer to divert the incoming flow of phosgene around the guide element and create an annular mixing passage in the static mixer. This allows for the use of an increased external radius of the effective phosgene flow while maintaining phosgene velocity by creating a blockage of the flow. The same flow, when transformed from a circular configuration to an annular configuration has an increased external radius, and a greater quantity of MDA jets can be placed along the increased radius, thus increasing the overall homogeneity of the mixture. Further, the cross-sectional area of the annular passage section of phosgene defined around the guide element controls the velocity of phosgene which facilitates the mixing of MDA injected through the jets into the phosgene. | 10-06-2011 |
| Patent application number | Description | Published |
|---|
| 20090029573 | Contact Device - A contact device is provided, the device having at least a first contact region for electrical connection to an electric line and at least a second contact region for electrical connection to a flexible printed circuit board other contact medium which may damaged by repeated soldering. The first contact region and the second contact region are electrically connected. Between the first contact region and the second contact region, a third region is provided which has a lower thermal conductivity per unit length than the first contact region and/or the second contact region. | 01-29-2009 |
| 20090061657 | HOLDER FOR A FLEXIBLE CIRCUIT BOARD - A holder with a device for holding a flexible circuit board is provided. The holder comprises at least one further device for holding at least one component such that the component may be electrically connected to or disconnected from the circuit board. | 03-05-2009 |
| 20100055967 | Electronic Module Having A Plug Connection - A module, particularly an electronic module of a commercial vehicle, includes at least one plug connection, having a plug element and a mating plug element, by which an electrical connection can be established when plugged together. At least one of the plug elements is mounted floatingly or movably within a clearance. A method for assembling the module plugs together the plug elements, at least one of the plug elements moving within a clearance relative to the mounting thereof. | 03-04-2010 |
| 20100068910 | SECURED PLUG CONNECTION AND METHOD FOR ITS PRODUCTION - A plug connection between electrical and/or electronic components, in which electrical plug contacts of a plug which is arranged directly adjacently to one component are inserted into a socket which is arranged directly adjacently to the other component, with the components being interlocked with one another by a connection arrangement or being combined to form an assembly, and in which a separate plug connection securing arrangement which is independent of the connection arrangement of the components is provided to secure the plug connection against movements of the plug relative to the socket and vice versa. | 03-18-2010 |
| Patent application number | Description | Published |
|---|
| 20090291072 | MEANS AND METHODS FOR THE TREATMENT OF TUMOROUS DISEASES - Provided are pharmaceutical means and methods for the prevention, treatment or amelioration of indolent or aggressive B cell non-Hodgkin lymphoma (B NHL) and B cell leukemia comprising the administration of a bispecific single chain antibody construct to a subject in the need thereof and the use of said bispecific single chain antibody construct for the preparation of a pharmaceutical composition for the prevention, treatment or amelioration of indolent or aggressive B cell non-Hodgkin lymphoma (B NHL) and B cell leukemia, whereby said construct is to be administered for at least 1 week in specified daily doses. Moreover, the invention relates to kits comprising a bispecific single chain antibody construct to be used in accordance with this invention. | 11-26-2009 |
| 20100150918 | CROSS-SPECIES-SPECIFIC BINDING DOMAIN - The present invention relates to a polypeptide comprising a human binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3 (epsilon) chain as well as to a process for the production of the mentioned polypeptide. The invention further relates to nucleic acids encoding for the polypeptide, to vectors comprising the same and to host cells comprising the vector. In another aspect, the invention provides for a pharmaceutical composition comprising the mentioned polypeptide and medical uses of the polypeptide. In a further aspect the invention provides a method for the identification of polypeptides comprising a cross-species specific binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3ε (CD3 epsilon). | 06-17-2010 |
| 20100183615 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS - The present invention relates to a polypeptide comprising a first human binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3 (epsilon) chain and a second binding domain capable of binding to EGFR, Her2/neu or IgE of a human and/or a non-chimpanzee primate as well as to a process for the production of the mentioned polypeptide. The invention further relates to nucleic acids encoding for the polypeptide, to vectors comprising the same and to host cells comprising the vector. In another aspect, the invention provides for a pharmaceutical composition comprising the mentioned polypeptide and medical uses of the polypeptide. | 07-22-2010 |
